Institutional Ownership Newamsterdam Pharma CO Nv Wt E (NAMSW)
This table provides information about the institutional ownership of Newamsterdam Pharma CO Nv Wt E (NAMSW). We have compiled data on the 12 institutions that hold shares in the stock, with a total of 1.3 Million shares, which have been reported (via 13F filing form) to have a value of $0.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Nov 14, 2025 Q3 2025 |
500,333
shares
|
$0
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
Ra Capital Management, L.P.
Boston, MA |
Nov 14, 2025 Q3 2025 |
333,333
shares
|
$0
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Affinity Asset Advisors, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
245,000
shares
|
$0
0.0% of portfolio
|
Q2 2025
Added 1.26%
|
|
|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
Nov 14, 2025 Q3 2025 |
100,000
shares
|
$0
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Nov 14, 2025 Q3 2025 |
92,787
shares
|
$0
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
Laurion Capital Management LP
New York, NY |
Nov 14, 2025 Q3 2025 |
16,666
shares
|
$0
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
Vestcor Inc
Fredericton, A3 |
Nov 13, 2025 Q3 2025 |
9,632
shares
|
$0
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
Cibc Private Wealth Group, LLC
|
Nov 21, 2025 Q3 2025 |
1,250
shares
|
$0
0.0% of portfolio
|
Q3 2025
Added 25.0%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
512
shares
|
$0
0.0% of portfolio
|
Q3 2025
Reduced 48.44%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|